Prostatic artery embolisation (PAE) is a minimally invasive, non-surgical procedure used to treat benign prostatic hyperplasia (BPH). BPH is a non-cancerous enlargement of the prostate gland. It normally affects men over 40, and two out of every ten men with the condition will eventually require a procedure to relieve its symptoms.
PAE involves blocking the blood supply to the enlarged prostate, which causes the gland to shrink over time. This procedure is typically performed by an interventional radiologist using small catheters (tubes) under specialised imaging guidance.
PAE works by reducing blood flow to the prostate, which causes the gland to shrink over time. The procedure is performed by inserting a thin tube (catheter) into a blood vessel, usually in the groin or left wrist. After numbing the area with local anaesthetic, the doctor uses real-time X-ray imaging and a special dye to guide the catheter to the blood vessels that supply the prostate.As the dye moves through the body, you may feel a brief warm sensation or the urge to urinate, which quickly passes. Once the correct location is reached, tiny particles — smaller than a strand of hair — are released to block the blood supply to the prostate.
Prostatic artery embolisation offers several advantages for individuals with benign prostatic hyperplasia, particularly those who may not be suitable for traditional surgery. Key benefits include:·
Prostatic artery embolisation (PAE) is primarily used to manage anyone with symptoms caused by benign prostatic hyperplasia (BPH).
It may be considered in the following situations:
While prostatic artery embolisation (PAE) is a promising treatment for many patients, it has certain limitations:
It is important to discuss with your healthcare provider on whether PAE is the most appropriate option for your condition.
Prostatic artery embolisation (PAE) is generally considered safe, but as with any medical procedure, there are potential risks and safety considerations:
Preparation for prostatic artery embolisation (PAE) involves several important steps to ensure the procedure is carried out safely and effectively. Your healthcare team will provide personalised instructions, but general preparations include:
Knowing what to expect on the day of your prostatic artery embolisation (PAE) can help reduce anxiety and make you feel more prepared.
Recovery following prostatic artery embolisation (PAE) is usually straightforward, with most patients experiencing only mild side effects. You will be given an antibiotic and medicines to reduce the inflammation (e.g., ibuprofen) to take for few days. Understanding what to expect during the days and weeks after the procedure can help you feel more prepared:
While traditional surgical treatments for an enlarged prostate may carry a risk of sexual side effects such as erectile dysfunction or retrograde ejaculation, prostatic artery embolisation has shown a lower risk of these complications. Most patients maintain normal sexual function after the procedure.
Many patients begin to notice relief from urinary symptoms within two to six weeks following the procedure. However, the prostate continues to shrink gradually over several months, and full benefits may not be felt until three to six months post-procedure.
Prostatic artery embolisation is typically recommended for men with moderately to significantly enlarged prostates, often greater than 40 grams in volume. However, suitability also depends on factors such as arterial anatomy and symptom severity. Imaging and clinical evaluation are used to determine if the procedure is appropriate for each patient.
Yale Medicine. (n.d.). Prostatic artery embolization. https://www.yalemedicine.org/conditions/prostatic-artery-embolization
Barbosa, R. M., Moreira, A. M., & Carnevale, F. C. (2023). Prostatic artery embolisation for benign prostatic hyperplasia. The Lancet Regional Health – Europe, 27, 100591. https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(23)00091-1/fulltext
de Assis, A. M., Moreira, A. M., de Paula Rodrigues, V. C., Yoshinaga, E. M., Antunes, A. A., Srougi, M., & Carnevale, F. C. (2021). Prostatic artery embolization for benign prostatic hyperplasia: A review of anatomy and technique. RadioGraphics, 41(5), 1401–1417. https://pubs.rsna.org/doi/full/10.1148/rg.2021200144
McWilliams, J. P. (2022). Commentary on: Prostatic artery embolization vs. transurethral resection of the prostate for benign prostatic hyperplasia: 2-year outcomes from a randomised, open-label, single-centre trial. The Journal of Urology, 207(6), 1151–1152. https://www.auajournals.org/doi/10.1097/JU.0000000000003976
The information provided is not intended as medical advice. Terms of use. Information provided by SingHealth.
Get to know our doctors at SingHealth Hospitals in Singapore.
Get to know our doctors at SingHealth Hospitals in Singapore. here.